Publicacións en colaboración con investigadores/as de Hospital Miguel Servet (8)

2021

  1. SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients

    Medicina Intensiva

2020

  1. High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 447-455

  2. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 67, Núm. 7, pp. 391-399

2019

  1. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 735-744

2018

  1. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society)

    Lung Cancer, Vol. 118, pp. 119-127

2015

  1. Radiotherapyinduced breakthrough cancer pain: Is it possible to optimize its treatment?

    Revista de la Sociedad Espanola del Dolor, Vol. 22, Núm. 4, pp. 159-164

2013

  1. Survival of hematological patients after discharge from the intensive care unit: A prospective observational study

    Critical Care, Vol. 17, Núm. 6

2007

  1. Risk factors for candidaemia in critically ill patients: A prospective surveillance study

    Mycoses, Vol. 50, Núm. 4, pp. 302-310